جست‌وجوی استاد و پژوهشگر

• Medical Oncology
• Gynecological Oncology
• Sarcomas
• +۷ مورد دیگر

Anna Carbo Bague is an Adjunct Professor at the Department of Medical Sciences, University of Girona. She works as a Medical Oncologist at the Catalan Institute of Oncology in Girona, affiliated with Hospital Universitari Dr. Josep Trueta. Her academic roles include teaching Gynecology and Bioethics, as well as contributing to the Integral Oncology Master's program at the same university. PhD in Molecular Oncology (University of Girona, 2023) MSc in Molecular Oncology (Rey Juan Carlos University, 2019) Her research focuses on Cancer-Immunotherapy Interactions , Gynecological Oncology , and Sarcoma Studies , with particular emphasis on: Cutaneous and mucosal melanoma epidemiology Medical oncology during pandemics (OnCovid Study Group contributions) Real-world data analysis in endometrial cancer treatments Molecular profiling of mutated genes in melanoma Clinical trial participation (DAYDREAM, DORA, Immune4All) Observational cancer registries (GEICO 81-T, GEIS-78) Notable scientific contributions include: 4 high-impact publications on cancer-COVID-19 interactions Key research on comorbidity factors in oncology patients Oral presentation at ESGO Barcelona 2024 Professional networks: Active member of Spanish Ovarian Cancer Research Group (GEICO) Active member of Spanish Sarcoma Research Group (GEIS) European Society of Medical Oncology (ESMO) certified

• Stem Cells
• Diabetes Mellitus
• Congenital Hyperinsulinism
• +۴ مورد دیگر

Karen Cosgrove, BSc, PhD, MRSB is a Lecturer in the Division of Diabetes, Endocrinology & Gastroenterology within the Faculty of Biology, Medicine and Health at the University of Manchester. She leads an active research program focused on stem cells, diabetes, and congenital hyperinsulinism of infancy (CHI), with strong connections to clinical practice through Royal Manchester Children's Hospital and the Northern Centre for the treatment and study of hyperinsulinism (NorCHI). Her research interests center on two main areas: Stem Cells and Diabetes Mellitus, where she investigates deriving insulin-secreting cells from human embryonic stem cells and adult stem cells for potential transplantation therapy; and Congenital Hyperinsulinism of Infancy (CHI), where she studies the pathogenesis of this rare disease using tissue from pancreatectomies and has created unique cell lines for further research. Her work employs advanced techniques including live cell Ca 2+ imaging, patch-clamp electrophysiology, immunohistochemistry, gene microarrays, and quantitative PCR. Analysis of her recent publications reveals a strong focus on understanding the clinical manifestations of CHI, developing better monitoring approaches using continuous glucose monitoring, investigating the cellular and molecular mechanisms underlying the disease, and exploring novel therapeutic interventions. Her research bridges basic science with clinical applications, particularly in understanding how defects in pancreatic beta-cell ion channels contribute to CHI. Dr. Cosgrove is part of the Manchester Regenerative Medicine Network and her work contributes to UN Sustainable Development Goals related to good health and well-being. She has supervised 12 research projects and has published extensively, with 56 research outputs including articles, conference contributions, chapters, and review articles. Her laboratory is actively involved in the Northern Centre for the treatment and study of hyperinsulinism (NorCHI), working closely with clinicians at Royal Manchester Children's Hospital. The team studies pancreatic tissue from CHI patients to understand disease mechanisms and identify new treatment targets, with a particular focus on ion channel function in pancreatic beta-cells and the potential of stem cell-derived insulin-secreting cells for diabetes therapy.

• Clinical Sciences
• Cardiorespiratory Medicine and Haematology
• Biochemistry and Cell Biology
• +۳ مورد دیگر

Graeme Birdsey is an Associate Professor in Vascular Science at the National Heart & Lung Institute, part of Imperial College London's Faculty of Medicine. His research focuses on transcriptional and epigenetic regulation of endothelial cell gene expression in angiogenesis and lymphangiogenesis. He has held affiliations with the CDT in Chemical Biology, the Institute of Chemical Biology, the Stem Cell Regenerative Medicine Network, and the Vascular Science Network. Dr. Birdsey earned a BSc in Applied Biochemistry from Liverpool John Moores University and a PhD in Molecular Cell Biology from University College London (UCL). His postdoctoral training included work in Prof. Chris Danpure's lab (UCL) on alanine:glyoxylate aminotransferase (AGT) targeting, followed by studies on nitric oxide regulation under Prof. Patrick Vallance at UCL. His research spans vascular biology, with emphasis on ERG transcription factor roles in endothelial cell function, vascular inflammation, and disease mechanisms. Key areas include lymphatic malformations, cardiovascular diseases, and genetic syndromes linked to ERG mutations. His work integrates molecular biology, genomics, and 3D modeling approaches. Publications highlight contributions to vascular biology, including ERG's role in angiogenesis regulation, therapeutic strategies using ultrasound-microbubble systems, and genetic insights into rare diseases. His research bridges basic science and clinical applications in cardiovascular and inflammatory disorders.

• Breast Cancer
• Ovarian Cancer
• Genetic Counseling
• +۳ مورد دیگر

Niklas Loman is an Associate Professor and Principal Investigator at the Lund University Cancer Centre (LUCC), affiliated with Lund University. His primary roles include Consultant, Project Manager, and Supervisor in breast/ovarian cancer research. Research Focus: Loman’s work centers on breast and ovarian cancer, particularly BRCA1/2 mutations, genetic testing, immunometabolism dynamics, and clinical trial design. His contributions include the Sweden Cancerome Analysis Network-Breast (SCAN-B) initiative, a large-scale genomic analysis platform, and the NordicTrip phase III trial exploring chemotherapy combinations for triple-negative breast cancer. Publications & Projects: With 127 publications, his recent work includes studies on estrogen receptor-low breast cancers, longitudinal immunometabolic profiling, and genetic testing guidelines. Active projects include NordicTrip (2024–2029) and SCAN-B (since 2009), focusing on genomic insights and clinical implementation. Awards & Recognition: While no specific awards are listed, his contributions to breast cancer genomics and clinical trials reflect significant academic impact. Grants & Teams: Funded by Cancerfonden and Mrs. Berta Kamprad’s Cancer Foundation, Loman collaborates on translational research and organizes events like the LUCC Breast Retreat and seminars on HER2-positive/triple-negative cancers.

• Hematology
• Molecular Biology
• Genomics
• +۳ مورد دیگر

Sólja Frida Remisdóttir Veyhe is a visiting researcher at the University of Southern Denmark , affiliated with the Faculty of Health Sciences and the Department of Clinical Research within the Research Unit of Haematology (Odense) . Her work focuses on chronic lymphocytic leukemia (CLL) and molecular responses to ibrutinib therapy. Education: MSc in Biochemistry and Molecular Biology (June 2019) Her research integrates multi-omics approaches to study CLL progression, ibrutinib resistance mechanisms, and B cell dynamics. Key methodologies include genomic profiling, transcriptomics, and longitudinal patient analysis. Recent publications highlight her contributions to understanding low allelic burden BTK mutations in ibrutinib resistance and developing multi-omics frameworks for treatment response evaluation. Committee Membership: Member of the Clinical Institute Council at SDU (2021–2024)

• Hematology
• Oncology
• Genetics
• +۳ مورد دیگر

Marcus Høy Hansen is a researcher at the Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, and affiliated with the Research Unit of Haematology (Odense). His work focuses on hematology, oncology, and genomic analysis of blood cancers. Research interests include: Molecular mechanisms in B-cell malignancies Multi-omics approaches to treatment response evaluation Somatic mutation detection using liquid biopsy Targeted sequencing for risk stratification in lymphomas His recent publications analyze: Longitudinal ibrutinib response in chronic lymphocytic leukemia Comparative mutation detection in non-Hodgkin lymphoma MYC/BCL2 aberrations in diffuse large B-cell lymphoma Genomic overlap between myeloproliferative neoplasms and lymphoma Labs & teams: Research Unit of Haematology (Odense) collaborating with Odense University Hospital (OUH) and Karolinska Institutet (KI).

• Biochemistry
• Genetics
• Molecular Biology
• +۵ مورد دیگر

Gitte Hoffmann Bruun is a researcher at the Department of Biochemistry and Molecular Biology, University of Southern Denmark, specializing in translational biology. Her work bridges genetic research and molecular medicine, focusing on RNA splicing mechanisms and genetic susceptibility to diseases. Research Interests: Biochemistry, Genetics, Molecular Biology, RNA Splicing, Exome Sequencing, and Genetic Susceptibility. Bruun's research leverages advanced bioinformatics and molecular biology techniques, such as deep learning models for predicting protein-RNA binding effects and exome sequencing to identify disease-related genes. Her work has applications in developing allele-specific therapies and antisense oligonucleotide-based treatments. Her publications and patents highlight a strong emphasis on splice switching oligonucleotides, pseudoexon targeting, and Mycobacterial infection genetics. These contributions underscore her role in translational research linking computational biology to clinical applications.

• Horticultural Crop Improvement
• Genetic Transformation
• Gene Editing
• +۵ مورد دیگر

Guo-Qing Song is a Professor and Associate Director of the Plant Biotechnology Resource & Outreach Center at Michigan State University 's Department of Horticulture. With over 15 years of faculty experience at MSU, his work integrates genetic transformation , gene editing , and biotechnology to improve horticultural crops like blueberry, grape, and cherry. Joined MSU in 2007 Appointment: 15% Teaching, 30% Research, 50% Outreach Previously: Research Associate at MSU (2002-2007) and Mitsui Chemical (2000-2002) Research Interests focus on: Basic Research : Molecular basis of chilling-mediated flowering in woody plants, MADS-box K-domain applications for yield, VcFT/SOC1 genes in blueberry flowering, and phytohormone interactions . Applied Research : Developing GM crops for abiotic tolerance (cold/heat/drought), transgrafting with siRNAs, and stable transformation systems for 30+ plant species. His scientific contributions include: Over 50 peer-reviewed publications (2004-present) Key patents on K-domain technology and transgrafting Recipient of the Outstanding International Horticulturalist Award (2024) Co-developer of CRISPR-Cas9 protocols for woody plants Outreach constitutes 50% of his appointment, focusing on: Training in plant transformation and gene editing Technical support for biotechnology adoption in specialty crops Developing micropropagation systems for fruit crops

Nicholas Zorkoمشاهده پروفایل

استادیار

• Prostate Cancer
• Immunotherapy
• Natural Killer (NK) Cell Therapy
• +۴ مورد دیگر

Nicholas Zorko, MD, PhD, is an Assistant Professor of Medicine at the University of Minnesota. His work centers on advancing NK cell-based immunotherapies for prostate and other solid tumors, with a focus on B7-H3 and PSMA-targeted tri-specific killer engagers (TriKEs). Research Interests Targeting B7-H3 and PSMA in prostate cancer immunotherapy Enhancing NK cell function in "cold" tumor microenvironments Development of off-the-shelf CAR NK cell therapies Investigating HLA class I expression and immune evasion mechanisms Scientific Contributions The 15 most recent publications (2025-2023) demonstrate expertise in tumor immunology, tri-specific antibody engineering, and pan-cancer therapeutic strategies. Key trends include optimizing radioligand therapy for prostate cancer, characterizing immune cell infiltration in solid tumors, and addressing adverse events in T-cell and NK cell therapies.

• Human T Cell Immune Responses
• HLA Molecules
• HIV Vaccine Development
• +۴ مورد دیگر

Professor Andrew McMichael is a distinguished academic in the Nuffield Department of Medicine at the University of Oxford . With over 50 years of experience in immunology, he has been pivotal in elucidating T cell immune responses, particularly focusing on HLA-restricted CD8 T cells and their role in HIV infection and vaccination strategies. Professor of Molecular Medicine Member of Nuffield Department of Medicine Collaborator with OHSU's Louis Picker His research spans three decades, transitioning from influenza to HIV studies, and currently centers on HLA-E restricted immune responses and their potential in universal immunotherapies. Key areas include: Analysis of early immune responses in HIV infection Investigation of viral escape mechanisms through epitope mutation Development of CMV-vectored SIV vaccines with HLA-E restricted T cells Structural studies of HLA-E-peptide complexes using crystallography and SAXS Exploration of non-classical HLA molecules in immune regulation Translational approaches to harness cellular immunity for vaccine design Publications highlight his team's work on HLA-E ligand diversity , NK cell modulation , and HLA-B*27 autoimmunity connections. Collaborations with Adrian Hill, Sarah Gilbert, and Tomas Hanke demonstrate his integrative approach to medical science. His laboratory continues to pioneer research on virus-specific and tumor-specific HLA-E restricted T cells , aiming to develop broadly applicable immunotherapies due to HLA-E's limited polymorphism.

• Medical Genetics
• Ophthalmology
• Genomics
• +۶ مورد دیگر

Professor Kathryn Burdon is Deputy Director of the Menzies Institute for Medical Research at the University of Tasmania. She holds a Professorial Research Fellowship and leads the Genetics and Cancer Theme. Her research focuses on identifying genetic factors underlying eye diseases such as glaucoma, cataracts, and keratoconus, with a particular emphasis on pediatric cases. She also investigates genetic contributions to multiple sclerosis and cardiovascular conditions. Education: PhD (2004) in pediatric cataract genetics from University of Tasmania; BSc(Hons) in albinism genetics (1999). Postdoctoral training at Wake Forest University. Research Interests Gene discovery for blinding eye diseases using whole genome sequencing and supercomputing analysis Role of genetic and environmental factors in treatment response (e.g., anti-VEGF therapy for macular degeneration) Utilization of the Tasmanian Ophthalmic Biobank and population records for genetic studies Development of zebrafish models to study disease mechanisms Article Trends Recent work focuses on pediatric cataract genetics, diabetic maculopathy GWAS, and polygenic risk scores for glaucoma. Emphasis on translating genetic findings into clinical care through predictive testing and personalized therapies. Awards Menzies Institute Academic Mentoring Award (2022) NHMRC Fellowships (Peter Doherty, Senior Research) Invited lectures at major ophthalmology and genetics conferences Grants & Supervision $2M+ in NHMRC and international grants for gene discovery projects Supervised over 20 PhD/Masters students on topics like EBV-MS links and pediatric cataract genetics Labs & Collaborations Leads the Tasmanian Ophthalmic Biobank and collaborates with global groups (Flinders University, Harvard, University of Melbourne) on multi-ethnic genetic studies.

• Molecular plant pathology
• Proteomics
• Metabolomics
• +۳ مورد دیگر

Associate Professor Kar-Chun Tan is affiliated with Curtin University's School of Molecular and Life Sciences within the Faculty of Science and Engineering. He leads the 'Septoria nodorum blotch biology' research program at the Centre for Crop Disease Management (CCDM). His work focuses on molecular plant pathology, proteomics, metabolomics, and genetic mapping of wheat to combat fungal pathogens. Key research areas include necrotrophic effector identification, transcription factor regulation of virulence, and wheat defensome mechanisms. Dr. Tan has received significant recognition, including a 2014 Eureka Prize finalist award for Sustainable Agriculture and a 2005 Western Australian Young Achiever Award semifinalist nomination. His research has led to advancements in understanding fungal pathogen interactions with wheat, including the role of transcription factors like PnPf2 in effector gene expression. His publications span proteomic analyses of oomycetes, transcriptional regulation in fungal pathogens, and genetic mapping of wheat resistance genes. Collaborative projects include studies on Septoria nodorum blotch dynamics, phosphite action mechanisms in oomycetes, and the role of accessory chromosomes in pathogen virulence. Tan's work bridges molecular biology and agricultural applications, aiming to enhance crop resilience against fungal diseases.

• Proteomics
• Bioinformatics
• Cancer Research
• +۴ مورد دیگر

Yun-ping Zhu is a prominent professor in proteomics and bioinformatics at the Chinese Academy of Medical Sciences, School of Basic Medical Sciences. With 173 publications, an h-index of 37, and over 6,654 citations, Dr. Zhu has established significant expertise in proteomics infrastructure development, cancer research, and multi-omics integration methods. Dr. Zhu's research focuses on proteomics data management systems including iProX and ProteomeXchange consortium contributions, cancer subtype analysis using advanced computational approaches like MoGCN, and protein interaction networks with applications in clinical diagnostics. Their work bridges computational biology with practical medical applications, particularly in liver cancer and other malignancies. The publication record spanning from 2004 to 2022 demonstrates consistent research productivity with notable contributions to large-scale proteomics data standards and infrastructure. Recent work has focused on multi-omics integration methods for cancer subtype classification and improving data management practices for clinical proteomics. Dr. Zhu maintains extensive collaborations, particularly with F. He (a senior researcher with 451 publications), reflecting strong integration within the Chinese proteomics research community and international consortia.

Julia Carnevaleمشاهده پروفایل

پزشک-پژوهشگر

• Gastrointestinal Oncology
• Cancer Immunotherapy
• CRISPR Engineering
• +۳ مورد دیگر

Dr. Julia Carnevale is a physician-scientist at the University of California San Francisco (UCSF), specializing in gastrointestinal oncology and cancer immunotherapy. Her research focuses on engineering more potent T cell therapies for cancer treatment using CRISPR technology and molecular profiling to overcome tumor microenvironment suppression.

Melike Pekmezciمشاهده پروفایل

استادیار بالینی

• Neuropathology
• Ocular Pathology
• Molecular Oncology
• +۳ مورد دیگر

Dr. Melike Pekmezci is a clinical pathologist at the University of California San Francisco (UCSF) School of Medicine, Department of Pathology , specializing in tumors and abnormalities of the central nervous system and ocular tissues. Education: M.D., Hacettepe University Faculty of Medicine (2004) Ophthalmology Residency, Gazi University (2007) Pathology Residency, Loyola University Medical Center (2011) Pathology Residency & Fellowships, UCSF (2012–2016) Research Focus: Molecular classification of brain and eye tumors Identification of diagnostic/prognostic biomarkers Integration of genetic and epigenetic profiling in tumor management Collaborative studies on neurofibromatosis and gliomas Scientific Contributions: Over 75 peer-reviewed publications, including key studies on CNS angiocentric tumors, glioma evolution, and immunotherapy applications. Active in developing AI-driven diagnostic models for glioma detection. Professional Affiliations: United States & Canadian Academy of Pathology American Association of Neuropathologists Verhoeff-Zimmerman Society American Association of Ophthalmic Oncologists and Pathologists